Anrei medical founded in 2006, it's a design and production expert in the field of minimally invasive medical devices. The products have obtained EU, CE certification and Chinese CFDA registration, have a mature sales network and extensive market coverage in China, and are exported to overseas markets such as Europe, Southeast Asia, and the Americas on a large scale. In 2016, Anrui successfully introduced the United States CBridge Capital and completed the A round of financing. After more than ten years of innovation and practice, it currently has two production and research bases in Hangzhou and Changzhou, three trading companies and offices in Tianjin, Beijing and Guangzhou, more than 1,000 domestic distributors and more than 80 overseas cooperative agents.